MedTrace Logo

Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure

NCT03806998 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2019-01-16

No results posted yet for this study

Summary

The aim of the study is to demonstrate that a ketoacid supplement in patients with stage III to IV chronic renal failure, reduces the excretion of urinary urea nitrogen

Conditions

  • Renal Failure

Interventions

DIETARY_SUPPLEMENT

Ketoacids

Provision of 1 Tablet containing 630 mg of ketoacids every 5 kg of body weight during 16 weeks

DIETARY_SUPPLEMENT

Placebo

Provision of placebo capsules similar to active supplement

Sponsors & Collaborators

  • Servicio de Salud Metropolitano Oriente

    collaborator UNKNOWN

  • University of Chile

    lead OTHER

Principal Investigators

  • Daniel Bunout, MD · INTA University of Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-10-01
Completion
2018-10-01

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03806998 on ClinicalTrials.gov